Correlation Between Goldman Sachs and Biotechnology Ultrasector
Can any of the company-specific risk be diversified away by investing in both Goldman Sachs and Biotechnology Ultrasector at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Goldman Sachs and Biotechnology Ultrasector into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Goldman Sachs Technology and Biotechnology Ultrasector Profund, you can compare the effects of market volatilities on Goldman Sachs and Biotechnology Ultrasector and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Goldman Sachs with a short position of Biotechnology Ultrasector. Check out your portfolio center. Please also check ongoing floating volatility patterns of Goldman Sachs and Biotechnology Ultrasector.
Diversification Opportunities for Goldman Sachs and Biotechnology Ultrasector
-0.17 | Correlation Coefficient |
Good diversification
The 3 months correlation between Goldman and Biotechnology is -0.17. Overlapping area represents the amount of risk that can be diversified away by holding Goldman Sachs Technology and Biotechnology Ultrasector Prof in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biotechnology Ultrasector and Goldman Sachs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Goldman Sachs Technology are associated (or correlated) with Biotechnology Ultrasector. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biotechnology Ultrasector has no effect on the direction of Goldman Sachs i.e., Goldman Sachs and Biotechnology Ultrasector go up and down completely randomly.
Pair Corralation between Goldman Sachs and Biotechnology Ultrasector
Assuming the 90 days horizon Goldman Sachs is expected to generate 1.04 times less return on investment than Biotechnology Ultrasector. But when comparing it to its historical volatility, Goldman Sachs Technology is 2.19 times less risky than Biotechnology Ultrasector. It trades about 0.12 of its potential returns per unit of risk. Biotechnology Ultrasector Profund is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 4,913 in Biotechnology Ultrasector Profund on September 4, 2024 and sell it today you would earn a total of 1,902 from holding Biotechnology Ultrasector Profund or generate 38.71% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Goldman Sachs Technology vs. Biotechnology Ultrasector Prof
Performance |
| Timeline |
| Goldman Sachs Technology |
| Biotechnology Ultrasector |
Goldman Sachs and Biotechnology Ultrasector Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Goldman Sachs and Biotechnology Ultrasector
The main advantage of trading using opposite Goldman Sachs and Biotechnology Ultrasector positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Goldman Sachs position performs unexpectedly, Biotechnology Ultrasector can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotechnology Ultrasector will offset losses from the drop in Biotechnology Ultrasector's long position.| Goldman Sachs vs. Goldman Sachs Clean | Goldman Sachs vs. Goldman Sachs Clean | Goldman Sachs vs. Goldman Sachs Clean | Goldman Sachs vs. Goldman Sachs Clean |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Transaction History View history of all your transactions and understand their impact on performance | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |